Intense Neoadjuvant ADT May Not Improve Post-RP Outcomes in High-Risk Prostate Cancer
Neoadjuvant androgen deprivation therapy prior to prostate cancer surgery is feasible, investigators noted.
Radical Prostatectomy
PLND Extent During Prostate Surgery Linked With Perioperative Complications
The technical challenges and potential complications of extended PLND warrant careful consideration, according to investigators.
Prostate, Kidney, and Pancreas Surgery Utilization Rates Differ by Income
Study findings corroborate previous research linking higher income with increased healthcare utilization.
Salvage Prostatectomy Complication Rates Differ by Primary PCa Therapy
Primary focal and radiation therapy for prostate cancer are associated with different rates of perioperative complications and long-term urinary continence recovery.
Localized PCa Therapies Safely Delivered During COVID-19 Peak at NYC Center
A cancer center in New York City safely managed patients with localized prostate cancer during the height of the COVID-19 pandemic in 2020, providing insights for handling a second COVID-19 wave.
RT After Artificial Urinary Sphincter Insertion Ups Urethral Atrophy Risk
Urethral atrophy occurs significantly more frequently and earlier in radical prostatectomy patients who receive radiation therapy after rather than before artificial urinary sphincter insertion, a study found.
Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Radiation Therapy After Prostate Surgery Worsens Sexual, Urinary Function
Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.
Sarcopenia Ups Risk of Sexual Dysfunction After Nerve-Sparing RARP
Sarcopenia prior to nerve-sparing robot-assisted radical prostatectomy is significantly associated with sexual dysfunction after the surgery, according to investigators.
Intense Neoadjuvant ADT for High-Risk PCa Improves Pathologic Response
After receiving intense hormone therapy prior to radical prostatectomy, one-fifth of men with high-risk localized prostate cancer had no tumor or residual tumor smaller than 5 mm following surgery, a study found.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...